首页> European journal of radiology> Metabolic response assessment with 18F-FDG-PET/CT is superior to modified RECIST for the evaluation of response to platinum-based doublet chemotherapy in malignant pleural mesothelioma.

Metabolic response assessment with 18F-FDG-PET/CT is superior to modified RECIST for the evaluation of response to platinum-based doublet chemotherapy in malignant pleural mesothelioma.

导出 LinkOut

翻译打印收藏纠错

第一作者： Shingo,Kanemura

第一单位： Department of Respiratory Medicine, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya, Hyogo 663-8501, Japan.

作者： Shingo,Kanemura ^[1] ; Kozo,Kuribayashi ^[2] ; Norihiko,Funaguchi ^[3] ; Eisuke,Shibata ^[1] ; Koji,Mikami ^[1] ; Hiroshi,Doi ^[4] ; Kazuhiro,Kitajima ^[5] ; Seiki,Hasegawa ^[6] ; Takashi,Nakano ^[1]

作者单位： Department of Respiratory Medicine, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya, Hyogo 663-8501, Japan. ^[1] Department of Respiratory Medicine, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya, Hyogo 663-8501, Japan. Electronic address: kuririn@hyo-med.ac.jp. ^[2] Department of Respiratory Medicine, Murakami Memorial Hospital, Asahi University, 3-23 Hashimoto-cho, Gifu 500-8523, Japan. ^[3] Department of Radiology, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya, Hyogo 663-8501, Japan. ^[4] Division of Nuclear Medicine and PET center, Department of Radiology, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya, Hyogo 663-8501, Japan. ^[5] Department of Thoracic Surgery, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya, Hyogo 663-8501, Japan. ^[6]

关键词 Chemotherapy Malignant pleural mesothelioma Metabolic response mRECIST